Intuitive Surgical (ISRG)
(Delayed Data from NSDQ)
$463.43 USD
-0.19 (-0.04%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $464.30 +0.88 (0.19%) 7:58 PM ET
1-Strong Buy of 5 1
F Value D Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Intuitive Surgical, Inc. [ISRG]
Reports for Purchase
Showing records 281 - 300 ( 407 total )
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
3Q15 Preview: MedTech Fundamentals Remain Intact Despite Market Volatility
Provider: WEDBUSH SECURITIES INC.
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
3Q15 Preview: MedTech Fundamentals Remain Intact Despite Market Volatility
Provider: WEDBUSH SECURITIES INC.
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Latest Competitive Dynamics in Robotic Surgery Are Interesting, But Not Worrisome; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Latest Competitive Dynamics in Robotic Surgery Are Interesting, But Not Worrisome; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Robotic Surgery Update from the SLS Conference - Day 1
Provider: WEDBUSH SECURITIES INC.
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Medical Devices - Key Takeaways from the Wedbush PacGrow Healthcare Conference
Provider: WEDBUSH SECURITIES INC.
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Key Takeaways from the Wedbush PacGrow Healthcare Conference
Provider: WEDBUSH SECURITIES INC.
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
No Concerns for ISRG Following Day 1 of the FDA Workshop on Robotic-Assisted Surgery Devices; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
2Q Review: Robust da Vinci Procedure Adoption; Raising PT to $650; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Medical Devices - 2Q15 Preview: MedTech Underlying Fundamentals Healthy and Outlook for 2H15
Provider: WEDBUSH SECURITIES INC.
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
2Q15 Preview: MedTech Underlying Fundamentals Healthy and Outlook for 2H15 Remains Positive
Provider: WEDBUSH SECURITIES INC.
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Medical Devices - Takeaways from J-J''s 2Q15 Results
Provider: WEDBUSH SECURITIES INC.
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
ROLAAR Data Positive for da Vinci Adoption in Colorectal Surgery; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
ROLAAR Data Positive for da Vinci Adoption in Colorectal Surgery; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.